MetaADEDB 2.0 @ LMMD
Roflumilast
(MNDBXUUTURYVHR-UHFFFAOYSA-N)
Structure
SMILES
FC(Oc1ccc(cc1OCC1CC1)C(=O)Nc1c(Cl)cncc1Cl)F
Type(s)
Approved
ATC code(s)
R03DX07
Molecular Formula:
C17H14Cl2F2N2O3
Molecular Weight:
403.207
Log P:
5.1039
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
60.45
CAS Number(s):
162401-32-3
Synonym(s)
1.
Roflumilast
2.
3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-di-chloropyrid-4-yl)benzamide
3.
daliresp
External Link(s)
MeSHC424423
PubChem Compound449193
BindingDB14774
ChEBI47657
CHEMBLCHEMBL193240
DrugBankDB01656
DrugCentral3531
IUPHAR/BPS Guide to PHARMACOLOGY6962
KEGGdr:D05744
Therapeutic Target DatabaseD0R4UW
D07GBA
ZINC592419
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Weight decreasedFAERS: 109
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
2NauseaFAERS: 101
Canada Vigilance: 1
16317827CTD
SIDER
Canada Vigilance
US FAERS
3HeadacheFAERS: 69
Canada Vigilance: 2
16317827CTD
SIDER
Canada Vigilance
US FAERS
4DizzinessFAERS: 59SIDER
US FAERS
5MalaiseFAERS: 53
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
6PneumoniaFAERS: 45
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
7TremorFAERS: 42
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
8AnxietyFAERS: 40SIDER
US FAERS
9Back PainFAERS: 34SIDER
US FAERS
10VomitingFAERS: 33SIDER
US FAERS
11AstheniaFAERS: 32
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
12Feeling abnormalFAERS: 27SIDER
US FAERS
13FatigueFAERS: 21SIDER
US FAERS
14Abdominal discomfortFAERS: 15US FAERS
15DehydrationFAERS: 15US FAERS
16NervousnessFAERS: 15SIDER
US FAERS
17Abdominal PainFAERS: 1416317827CTD
SIDER
US FAERS
18Intentional product misuseFAERS: 14US FAERS
19PainFAERS: 14US FAERS
20Suicide attemptFAERS: 14US FAERS
21Atrial FibrillationFAERS: 12SIDER
US FAERS
22Chest PainFAERS: 12US FAERS
23Drug dose omissionFAERS: 12US FAERS
24TachycardiaFAERS: 12US FAERS
25PalpitationsFAERS: 11SIDER
US FAERS
26ArthralgiaFAERS: 9US FAERS
27Drug ineffectiveFAERS: 9
Canada Vigilance: 6
Canada Vigilance
US FAERS
28DyspepsiaFAERS: 9SIDER
US FAERS
29Medication ErrorFAERS: 9US FAERS
30Unevaluable eventFAERS: 9US FAERS
31AgitationFAERS: 8US FAERS
32MyalgiaFAERS: 8SIDER
US FAERS
33PancreatitisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
34Respiratory FailureFAERS: 8US FAERS
35RestlessnessFAERS: 8US FAERS
36Adverse eventFAERS: 7US FAERS
37CryingFAERS: 7US FAERS
38General physical health deteriorationFAERS: 7US FAERS
39Feeling jitteryFAERS: 6US FAERS
40Mood swingsFAERS: 6US FAERS
41Myocardial InfarctionFAERS: 6US FAERS
42Product use issueFAERS: 6US FAERS
43PruritusFAERS: 6US FAERS
44SomnolenceFAERS: 6US FAERS
45Wrong technique in drug usage processFAERS: 6US FAERS
46AbasiaFAERS: 5US FAERS
47BronchitisFAERS: 5US FAERS
48EpistaxisFAERS: 5US FAERS
49InfluenzaFAERS: 5SIDER
US FAERS
50NasopharyngitisFAERS: 5US FAERS
51SyncopeFAERS: 5US FAERS
52UrticariaFAERS: 5SIDER
US FAERS
53Visual ImpairmentFAERS: 5US FAERS
54Activities of daily living impairedFAERS: 4US FAERS
55AsthmaFAERS: 416317827CTD
US FAERS
56Chest discomfortFAERS: 4US FAERS
57CholecystitisFAERS: 4US FAERS
58Completed SuicideFAERS: 4SIDER
US FAERS
59ConstipationFAERS: 4SIDER
US FAERS
60Deep Vein ThrombosisFAERS: 4US FAERS
61Depressed moodFAERS: 4US FAERS
62HypersensitivityFAERS: 4SIDER
US FAERS
63HypotensionFAERS: 4US FAERS
64Inappropriate schedule of drug administrationFAERS: 4US FAERS
65InfectionFAERS: 4SIDER
US FAERS
66Intestinal ObstructionFAERS: 4US FAERS
67Memory impairmentFAERS: 4US FAERS
68Musculoskeletal stiffnessFAERS: 4US FAERS
69RetchingFAERS: 4US FAERS
70Atrioventricular BlockFAERS: 3US FAERS
71Bone painFAERS: 3US FAERS
72BronchospasmFAERS: 3US FAERS
73Burning sensationFAERS: 3US FAERS
74Cerebrovascular accidentFAERS: 3US FAERS
75ChillsFAERS: 3US FAERS
76Cold sweatFAERS: 3US FAERS
77Deafness NeurosensoryFAERS: 3US FAERS
78ErythemaFAERS: 3US FAERS
79Food aversionFAERS: 3US FAERS
80HypoxiaFAERS: 3US FAERS
81Increased bronchial secretionFAERS: 3US FAERS
82Increased upper airway secretionFAERS: 3US FAERS
83LipomaFAERS: 3US FAERS
84Neck PainFAERS: 3US FAERS
85ParanoiaFAERS: 3US FAERS
86ProctitisFAERS: 3US FAERS
87Product use in unapproved indicationFAERS: 3US FAERS
88Productive CoughFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Pulmonary EmbolismFAERS: 3US FAERS
90Therapeutic response unexpectedFAERS: 3US FAERS
91ThrombosisFAERS: 3US FAERS
92TinnitusFAERS: 3US FAERS
93VasculitisFAERS: 3US FAERS
94AlopeciaFAERS: 2US FAERS
95Angina PectorisFAERS: 2US FAERS
96Aortic AneurysmFAERS: 2US FAERS
97Blood potassium decreasedFAERS: 2US FAERS
98Blood sodium decreasedFAERS: 2US FAERS
99Blood urine presentFAERS: 2US FAERS
100Cardiac ArrestFAERS: 2US FAERS
101Cardiovascular insufficiencyFAERS: 2US FAERS
102CheilitisFAERS: 2US FAERS
103Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
104ClaustrophobiaFAERS: 2US FAERS
105ColitisFAERS: 2US FAERS
106ConjunctivitisFAERS: 2US FAERS
107Disease ProgressionFAERS: 2US FAERS
108DisorientationFAERS: 2US FAERS
109Drug administration errorFAERS: 2US FAERS
110DysphoniaFAERS: 2US FAERS
111Failure to ThriveFAERS: 2US FAERS
112FlatulenceFAERS: 2US FAERS
113FlushingFAERS: 2US FAERS
114Gamma-Glutamyltransferase IncreasedFAERS: 2SIDER
US FAERS
115Guillain-Barre SyndromeFAERS: 2US FAERS
116HungerFAERS: 2US FAERS
117Intentional self-injuryFAERS: 2US FAERS
118Joint swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
119Lipase increasedFAERS: 2US FAERS
120Loss of personal independence in daily activitiesFAERS: 2US FAERS
121Mechanical ileusFAERS: 2US FAERS
122Mental status changesFAERS: 2US FAERS
123MonoplegiaFAERS: 2US FAERS
124NephrolithiasisFAERS: 2US FAERS
125Oropharyngeal painFAERS: 2US FAERS
126OverdoseFAERS: 2US FAERS
127Poor quality sleepFAERS: 2US FAERS
128Respiratory distressFAERS: 2US FAERS
129SepsisFAERS: 2US FAERS
130Sinus TachycardiaFAERS: 2US FAERS
131SinusitisFAERS: 2SIDER
US FAERS
132SubileusFAERS: 2US FAERS
133SwellingFAERS: 2US FAERS
134Terminal stateFAERS: 2US FAERS
135Therapy cessationFAERS: 2US FAERS
136Urinary RetentionFAERS: 2US FAERS
137Urinary tract infectionFAERS: 2SIDER
US FAERS
138Accidental overdoseFAERS: 1US FAERS
139Acute myocardial infarctionFAERS: 1US FAERS
140AgeusiaFAERS: 1US FAERS
141Alanine Aminotransferase IncreasedFAERS: 1US FAERS
142Anal UlcerFAERS: 1US FAERS
143Anaphylactic shockFAERS: 1US FAERS
144AngerFAERS: 1US FAERS
145ApathyFAERS: 1US FAERS
146AphagiaFAERS: 1US FAERS
147AppendicitisFAERS: 1US FAERS
148Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
149AsphyxiaFAERS: 1US FAERS
150AtelectasisFAERS: 1US FAERS
151AutoscopyFAERS: 1US FAERS
152Bacterial test positiveFAERS: 1US FAERS
153Basal cell carcinomaFAERS: 1US FAERS
154BedriddenFAERS: 1US FAERS
155BlindnessFAERS: 1US FAERS
156Blood cholesterol increasedFAERS: 1US FAERS
157Blood potassium increasedFAERS: 1US FAERS
158Blood triglycerides increasedFAERS: 1US FAERS
159Blue Toe SyndromeFAERS: 1US FAERS
160Bowel movement irregularityFAERS: 1US FAERS
161Bronchial secretion retentionFAERS: 1US FAERS
162BronchiectasisFAERS: 1US FAERS
163BronchopneumoniaFAERS: 1US FAERS
164BursitisFAERS: 1US FAERS
165CachexiaFAERS: 1US FAERS
166Calcium deficiencyFAERS: 1US FAERS
167Carcinoembryonic antigen increasedFAERS: 1US FAERS
168Cardiac FlutterFAERS: 1US FAERS
169CardiomegalyFAERS: 1US FAERS
170Cartilage injuryFAERS: 1US FAERS
171Cataract operationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
172Circumstance or information capable of leading to device use errorFAERS: 1US FAERS
173Compression fractureFAERS: 1US FAERS
174Coronary Artery DiseaseFAERS: 1US FAERS
175CystitisFAERS: 1US FAERS
176CystFAERS: 1US FAERS
177DeafnessFAERS: 1US FAERS
178DeliriumFAERS: 1US FAERS
179Device related infectionFAERS: 1US FAERS
180DisabilityFAERS: 1US FAERS
181DiscomfortFAERS: 1SIDER
US FAERS
182Drug DependenceFAERS: 1US FAERS
183Drug dispensing errorFAERS: 1US FAERS
184DysphemiaFAERS: 1US FAERS
185DystoniaFAERS: 1US FAERS
186DysuriaFAERS: 1US FAERS
187Early satietyFAERS: 1US FAERS
188Electrocardiogram abnormalFAERS: 1US FAERS
189Electrolyte imbalanceFAERS: 1US FAERS
190Emotional disorderFAERS: 1US FAERS
191EndocarditisFAERS: 1US FAERS
192EnteritisFAERS: 1US FAERS
193EosinophiliaFAERS: 1US FAERS
194Erythema MultiformeFAERS: 1US FAERS
195EuthanasiaFAERS: 1US FAERS
196ExophthalmosFAERS: 1US FAERS
197Extra dose administeredFAERS: 1US FAERS
198Eye painFAERS: 1US FAERS
199Food PoisoningFAERS: 1US FAERS
200FractureFAERS: 1US FAERS
201GastritisFAERS: 1SIDER
US FAERS
202Gastrointestinal motility disorderFAERS: 1US FAERS
203General physical condition abnormalFAERS: 1US FAERS
204Gingival blisterFAERS: 1US FAERS
205Glioblastoma MultiformeFAERS: 1US FAERS
206GoutFAERS: 1US FAERS
207Hypertensive crisisFAERS: 1US FAERS
208HyperthyroidismFAERS: 1US FAERS
209HypertrichosisFAERS: 1US FAERS
210HypophagiaFAERS: 1US FAERS
211Impaired driving abilityFAERS: 1US FAERS
212Incorrect drug administration rateFAERS: 1US FAERS
213InflammationFAERS: 1US FAERS
214LacerationFAERS: 1US FAERS
215Lactobacillus infectionFAERS: 1US FAERS
216LethargyFAERS: 1US FAERS
217LeukocytosisFAERS: 1US FAERS
218Lobar PneumoniaFAERS: 1US FAERS
219Lower respiratory tract infectionFAERS: 1US FAERS
220Mantle cell lymphomaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
221MenopauseFAERS: 1US FAERS
222Metabolic acidosisFAERS: 1US FAERS
223Metastatic NeoplasmFAERS: 1US FAERS
224Middle insomniaFAERS: 1US FAERS
225Nail bed disorderFAERS: 1US FAERS
226Negative thoughtsFAERS: 1US FAERS
227NeutropeniaFAERS: 1US FAERS
228No adverse eventFAERS: 1US FAERS
229Oxygen consumption decreasedFAERS: 1US FAERS
230Pancreatic carcinomaFAERS: 1US FAERS
231Panic DisorderFAERS: 1US FAERS
232PericarditisFAERS: 1US FAERS
233Peripheral artery bypassFAERS: 1US FAERS
234Personality ChangeFAERS: 1US FAERS
235PneumothoraxFAERS: 1US FAERS
236Procedural complicationFAERS: 1US FAERS
237Product dose omissionFAERS: 1US FAERS
238Psychiatric symptomFAERS: 1US FAERS
239Pulmonary HypertensionFAERS: 1US FAERS
240Pulmonary congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Pulmonary thrombosisFAERS: 1US FAERS
242RegurgitationFAERS: 1US FAERS
243Renal cystFAERS: 1US FAERS
244Respiratory tract congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
245Respiratory tract infection bacterialFAERS: 1US FAERS
246Restless Legs SyndromeFAERS: 1US FAERS
247Scan abnormalFAERS: 1US FAERS
248ScreamingFAERS: 1US FAERS
249Secretion dischargeFAERS: 1US FAERS
250Senile dementiaFAERS: 1US FAERS
251Septic ShockFAERS: 1US FAERS
252ShockFAERS: 1US FAERS
253Skin irritationFAERS: 1US FAERS
254Skin lesionFAERS: 1US FAERS
255Sleep disorder due to general medical condition, insomnia typeFAERS: 1US FAERS
256SneezingFAERS: 1US FAERS
257Squamous cell carcinomaFAERS: 1US FAERS
258StressFAERS: 1US FAERS
259Sudden Cardiac DeathFAERS: 1US FAERS
260TachyarrhythmiaFAERS: 1US FAERS
261Throat cancerFAERS: 1US FAERS
262Throat irritationFAERS: 1US FAERS
263Toxicity to various agentsFAERS: 1US FAERS
264Unresponsive to stimuliFAERS: 1US FAERS
265VIIth nerve paralysisFAERS: 1US FAERS
266Ventricular hypertrophyFAERS: 1US FAERS
267VertigoFAERS: 1SIDER
US FAERS
268WheezingFAERS: 1US FAERS
269AngioedemaSIDER
270Carcinoma of lungSIDER
271DermatitisSIDER
272Diarrhea16317827CTD
273DysgeusiaSIDER
274Gastrointestinal PainSIDER
275Inappropriate schedule of product administrationCanada Vigilance: 1Canada Vigilance
276InfestationSIDER
277MalnutritionSIDER
278Musculoskeletal discomfortSIDER
279RhinitisSIDER
280TensionSIDER
281nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.